ArticleScientific reports2025
Pelvic floor symptom progression increases risk for depression, while better physical performance is protective in Asian midlife women.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The relationship between the latent profiles of alexithymia and self-disclosure in female patients with pelvic floor dysfunction.Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
There is a lack of studies examining the role of women-specific factors in the development of depression in midlife women. Healthy women (45-69 years) were enrolled at baseline from a Singapore tertiary hospital and followed up 6.8 years later. Risk factors were ascertained using validated questionnaires, and physical performance was objectively measured. Changes in risk factors were calculated by subtracting baseline from follow-up values. Depressive symptoms were defined using a Center for Epidemiological Studies-Depression (CES-D) scale score ≥ 16 and/or use of anti-depression medication. Incident cases were new cases that emerged during follow-up. Modified Poisson regression analyses examined associations between risk factors and outcomes. After 6.8 years, depression developed in 131/825 (15.9%) participants. Improvements (1-standard deviation (SD)) increases in balance (adjusted relative risks, aRR:0.79, 95% confidence interval, CI:0.67-0.94), and one-SD increases in overall physical performance scores (0.80, 0.69-0.93) reduced risks for depression onset. Worsening menopausal symptom severity (1.91, 1.64-2.23) and pelvic floor dysfunction symptoms (1.53, 1.36-1.72) over 6.8 years increased depression risks, independent of age, ethnicity, education, marital status, hypertension, body mass index, baseline exposure and baseline CES-D levels. Worsening menopausal symptoms, pelvic floor dysfunction, and physical performance elevated depression risk, highlighting the need for early detection and intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.